Home

trka Operacija moguća Idite u krug teva sec filings pripremiti aukciji Neuropatija

DEF 14A
DEF 14A

DEF 14A
DEF 14A

Form 10-K
Form 10-K

Capital Research Global Investors increases ownership in TEVJF / Teva  Pharmaceutical Industries Ltd.
Capital Research Global Investors increases ownership in TEVJF / Teva Pharmaceutical Industries Ltd.

Stock Forecast Based On a Predictive Algorithm | I Know First |Stock  Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in  Teva Stock
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock

TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed  2022-05-03
TEVA PHARMACEUTICAL INDUSTRIES LTD Form 10-Q Quarterly Report Filed 2022-05-03

Form 10-K
Form 10-K

Form 10-K
Form 10-K

Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)

DEF 14A
DEF 14A

As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech

Teva Investor Relations on the App Store
Teva Investor Relations on the App Store

Teva announces $519 million FCPA settlement | The FCPA Blog
Teva announces $519 million FCPA settlement | The FCPA Blog

DEF 14A
DEF 14A

Stock Forecast Based On a Predictive Algorithm | I Know First |Stock  Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in  Teva Stock
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock

DEF 14A
DEF 14A

DEF 14A
DEF 14A

DEF 14A
DEF 14A

DEF 14A
DEF 14A

Teva Announces New Environmental, Social and Governance (ESG) Strategy and  Goals in 2020 Report | Business Wire
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire

DEF 14A
DEF 14A

Teva: New Generic Launches Will Benefit Earnings (NYSE:TEVA) | Seeking Alpha
Teva: New Generic Launches Will Benefit Earnings (NYSE:TEVA) | Seeking Alpha

DEF 14A
DEF 14A

Teva to shut down US site, cut many jobs
Teva to shut down US site, cut many jobs

Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.

Teva Gains 6.4% on Another Opioid Case Settlement
Teva Gains 6.4% on Another Opioid Case Settlement